<DOC>
	<DOCNO>NCT00193843</DOCNO>
	<brief_summary>To demonstrate whether addition Concurrent chemotherapy post-operative adjuvant radiotherapy OR shorten duration post-operative radiotherapy , administer 6 fraction / week instead 5 fraction / week improve local-regional control / overall survival high risk , locally advanced , resectable , squamous cell carcinoma oral cavity .</brief_summary>
	<brief_title>Oral Cancer Adjuvant Therapy ( OCAT ) Trial</brief_title>
	<detailed_description>Locally advanced , stage III IVA , resectable , squamous cell carcinomas oral cavity conventionally treat surgery , follow post-operative radiotherapy . Local-regional recurrence remain frequent cause failure treatment . The result conventional therapy dismal five-year survival le 30 % 60-80 % incidence local-regional failure within 3 year . There various known histological prognostic factor . The local-regional control overall survival extremely poor high risk patient poor prognostic factor . In attempt improve outcome high risk group , various alternative treatment policy addition chemotherapy radiotherapy alter fractionation schedule try . But till date , alternative treatment modality acceptable toxicity , available patient . Aims Of Study : To demonstrate whether addition Concurrent chemotherapy post-operative adjuvant radiotherapy OR shorten duration post-operative radiotherapy , administer 6 fraction / week instead 5 fraction / week improve local-regional control / overall survival high risk , locally advanced , resectable , squamous cell carcinoma oral cavity . Eligibility criterion : Locally advance , stage III IVA , resectable , squamous cell carcinomas oral cavity one follow poor prognostic factor extracapsular nodal extension , involvement &gt; 2 regional lymph node , margin resection invasive cancer Extensive soft tissue / skin infiltration require major reconstructive procedure . Peri-neural invasion positive lymph node . Lympho-vascular embolisation positive lymph node . Trial Design The eligible patient randomly allocate one three arm 1 . Arm 1 ( Control arm ) : Surgery follow conventional radiotherapy 2 . Arm 2 : Surgery follow Concurrent chemo-radiotherapy 3 . Arm 3 : Surgery follow Accelerated radiotherapy Surgery : Surgery three arm . Wide excision tumour appropriate nodal dissection reconstruction utilize accept criterion region involve do . Radiotherapy : Total dose radiotherapy 56 â€“ 60 Gy . Patients Arms 1 2 , five fraction per week six week . Patients Arm 3 , six fraction week five week . Chemotherapy : Patients Arm 2 get weekly chemotherapy ( Inj Cisplatin 30 mg / m2 ) Stratification : Patients stratify accord follow factor Site : Gingivo-buccal complex cancer Vs Tongue Floor mouth cancer . T stage . N stage . Extra-capsular spread ( Peri-nodal extension ) Surgical margin Extensive soft tissue infiltration End point Primary end point : Local-regional failure . Secondary end point : Overall survival . Other parameter assess Treatment related toxicity Protocol compliance Overall treatment time Quality life : assessment EORTC-QLQ-C30 EORTC-H &amp; N-35 Sample size : 900 pt ( 300 pt arm ) . Duration accrual : 7 year . Duration follow : 5 year . With minimum follow 2 year . Analysis : Intent treat analysis do . Interim analysis do 450 patient ( 150 pt arm )</detailed_description>
	<mesh_term>Mouth Neoplasms</mesh_term>
	<criteria>Previously untreated , resectable , locoregionally advanced , stage III &amp; IV , biopsyproven squamous cell carcinoma oral cavity . ( Clinically low stage patient also include upstaged pathological stage III IV Surgery ) One follow must present : extracapsular nodal extension , involvement &gt; 2 regional lymph node , margin resection invasive cancer ( histopathology ) Extensive soft tissue / skin infiltration require major reconstructive procedure . Perineural invasion positive lymph node ( ) . Lymphovascular embolisation positive lymph node ( ) . Age &gt; 18 . Karnofsky performance status &gt; 60 . WBC &gt; 3500 , platelets &gt; 100,000 Serum creatinine &lt; 1.2 mg / m2 Signed studyspecific inform consent form . Protocol treatment must begin within 8 week surgery . Gross ( visible palpable ) residual disease leave surgery . Prior chemotherapy radiation therapy head neck region . Evidence distant metastasis . Any postoperative complication delay start adjuvant treatment 8 week . Presence synchronous concurrent head neck primary tumor . Prior malignancy within previous 5 year . Patients medical status candidate propose treatment . KPS &lt; 60 . Age &gt; 65 year . Poor expect follow .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Oral cancer</keyword>
	<keyword>Head neck surgery</keyword>
	<keyword>Accelerated radiotherapy</keyword>
	<keyword>Chemo-radiotherapy</keyword>
</DOC>